Enrica Marchi, Owen A. O’Connor: Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. In: Therapeutic Advances in Hematology. Band3, Nr.4, 2012, S.227–235, doi:10.1177/2040620712445330, PMID 23606933.
espacenet.com
worldwide.espacenet.com
Patent US9440979B2: Process for the preparation of pralatrexate. Angemeldet am 18. Juli 2013, veröffentlicht am 13. September 2016, Anmelder: Fresenius Kabi Oncology Ltd, Erfinder: Saswata Lahiri et al.
Thomas Kroner · Anita Margulies · Christian Taverna · Cristina Studer: Medikamente in der Tumortherapie. Springer Berlin Heidelberg, 2017, ISBN 978-3-662-55356-5, S.205 (eingeschränkte Vorschau in der Google-Buchsuche).
Enrica Marchi, Owen A. O’Connor: Safety and efficacy of pralatrexate in the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. In: Therapeutic Advances in Hematology. Band3, Nr.4, 2012, S.227–235, doi:10.1177/2040620712445330, PMID 23606933.
